Yaping Zhang on Platelet Adhesion Receptors
Yaping Zhang, Postdoc Associate at University of Illinois Chicago, shared on LinkedIn:
”Glad to participate in publishing the chapter “Platelet Adhesion Receptors” in the book Platelet Physiology I.
Andrew Mack, Yaping Zhang & Xiaoping Du
Platelet adhesion receptors are essential for platelet attachment, aggregation, and activation, which are critical for normal hemostasis and pathological thrombosis.
These receptors regulate where and how platelets adhere, influencing thrombus size and stability, and they trigger signaling pathways that coordinate with other adhesion and activation receptors to promote platelet spreading, secretion, clot retraction, and thrombus formation.
Platelets use several major receptor families—including integrins, LRR receptors such as GPIb-IX-V, immunoglobulin superfamily receptors like GPVI, and C-type lectins—to bind ligands such as collagen, von Willebrand factor, fibrinogen, and laminin, enabling interactions with vessel walls, other platelets, leukocytes, microbes, and tumor cells.
Because adhesion is central not only to hemostasis and thrombosis but also to inflammation and immune responses, targeting these receptors and their signaling pathways remains a key strategy for developing antithrombotic therapies.”
Read the chapter here.
Article: Platelet Adhesion Receptors
Authors: Andrew Mack, Yaping Zhang, Xiaoping Du
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 22, 2026, 16:45Shivangi Harankhedkar: Gene Therapy and CRISPR Advances in Hemoglobinopathies
-
Jun 22, 2026, 16:39Vikram Sinai Talaulikar: Haematology and Female Hormone Health Intersect at Multiple Levels
-
Jun 22, 2026, 16:35Sehrish Chaudhary: Advancing Transfusion Medicine Through Global Collaboration at ISBT 2026
-
Jun 22, 2026, 15:54Ready to Build Your ISTH 2026 Schedule?
-
Jun 22, 2026, 15:36Wolfgang Miesbach: What the Latest Gene Therapy Setbacks Mean for Haemophilia Care
-
Jun 22, 2026, 15:26Suvro Sankha Datta: Advancing Transfusion Medicine Through the Establishment of a Red Cell Genotyping Facility
-
Jun 22, 2026, 15:08Apixaban vs. Rivaroxaban in Acute VTE – Uncoiling COBRRA and Its Clinical Implications – Anticoagulation Forum
-
Jun 22, 2026, 14:41Ilkin Aygun Soyalp: Novel Substrate Recognition Broadens the Biological Role of DPF-3
-
Jun 22, 2026, 14:29Swarnava Roy: Linking Angiotensin Signaling to Oxidative Stress and Organ Damage in Sickle Cell Anemia